Methylprednisolone Recruiting Phase 2 Trials for Lupus Arthritis, Systemic Lupus Erythematosus Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03355482MRI Evaluation Assessing Synovitis to Address the Unmet Need for Reliable Endpoints in SLE
NCT03054259Rituximab Objective Outcome Measures Trial in SLE